logo

Infinity Pharmaceuticals Inc. (INFI)



Trade INFI now with
  Date
  Headline
1/5/2022 7:13:20 AM Infinity Pharma Expects Net Loss For 2022 To Range $45 Mln To $55 Mln
12/14/2021 7:37:00 AM Infinity Pharma Added To NASDAQ Biotechnology Index
12/10/2021 8:12:18 AM Infinity Pharma : Durable Clinical Benefit Seen With Eganelisib Combination In Breast Cancer Trial; Stock Up
9/7/2021 7:51:44 AM Infinity Pharma Appoints Robert Ilaria As Chief Medical Officer And Brian Schwartz To Board
8/10/2016 9:13:51 AM RBC Capital Markets Is Lowering Infinity Pharmaceuticals Inc. (INFI) 2016 Rev. Estimate To 18.7 M From 19.6 M
8/10/2016 9:13:27 AM RBC Capital Markets Is Raising Infinity Pharmaceuticals Inc. (INFI) 2017 Estimate To -1.34 From -1.67
8/10/2016 9:13:09 AM RBC Capital Markets Is Raising Infinity Pharmaceuticals Inc. (INFI) 2016 Estimate To -1.45 From -3.57
8/10/2016 9:12:51 AM RBC Capital Markets Is Increasing Infinity Pharmaceuticals Inc. (INFI) Q4 16 Estimate To -0.86 From -0.88
8/10/2016 9:12:32 AM RBC Capital Markets Is Cutting Infinity Pharmaceuticals Inc. (INFI) Q3 16 Estimate To -0.83 From -0.82
8/10/2016 9:12:15 AM RBC Capital Markets Is Increasing Infinity Pharmaceuticals Inc. (INFI) Q2 16 Estimate To 1.05 From -1.04
8/9/2016 8:12:41 PM Wedbush Reiterates Infinity Pharmaceuticals Inc. (INFI) At Neutral With $1 Down from $1.25 Price Target
8/9/2016 8:12:01 PM Wedbush Is Raising Infinity Pharmaceuticals Inc. (INFI) 2017 Estimate To -0.51 From -0.55
8/9/2016 8:11:47 PM Wedbush Is Raising Infinity Pharmaceuticals Inc. (INFI) 2016 Estimate To -1.52 From -3.24
8/9/2016 8:11:27 PM Wedbush Is Lowering Infinity Pharmaceuticals Inc. (INFI) 2016 Rev. Estimate To 18.7 M From 39.3 M
6/29/2016 8:54:27 AM RBC Capital Markets Is Lowering Infinity Pharmaceuticals Inc. (INFI) Q4 16 Estimate To -0.88 From -0.63